Diabetic eye disease associated with five-fold risk of severe COVID-19
People with diabetes and eye disease have a five-fold increased risk of requiring intubation when hospitalised with COVID-19.
Diabetic eye disease is a common complication of diabetes and is caused by damage to the small blood vessels in the eye. In 2014, the prevalence of diabetic retinopathy was 54.6% in people with type 1 diabetes and 30% in people with type 2 diabetes. A study, published in Diabetes Research and Clinical Practice by King’s College London, identified for the first time the risk associated with diabetic retinopathy - caused by high blood sugar levels damaging the back of the eyes - and COVID-19.
The study investigated 187 people with diabetes (179 with type 2 diabetes and eight with type 1 diabetes) hospitalised with COVID-19 at Guy’s and St Thomas’ NHS Foundation Trust between 12 March and 7 April 2020.
Diabetic retinopathy was reported in 67 (36%) of patients, the majority with background retinopathy. Of the 187 patients hospitalised with severe COVID-19, 26% were intubated – having a tube in your throat to help move air in and out of your lungs - and 45% of these patients had retinopathy. Retinopathy was associated with a five-fold increased risk for intubation. In the cohort, 32% of patients died and no association was observed between retinopathy and mortality.
The first author of the study, Dr Antonella Corcillo from the School of Cardiovascular Medicine and Sciences, said:
This is the first time that retinopathy has been linked to severe COVID-19 in people with diabetes. Retinopathy is a marker of damage to the blood vessels and our results suggest that such pre-existing damage to blood vessels may result in a more severe COVID-19 infection requiring intensive care treatment.
Senior author, Dr Janaka Karalliedde from King’s College London, said:
There is increasing evidence that there is significant damage to the blood vessels in the lung and other organs in patients hospitalised with severe COVID-19. People with diabetes are at high risk of vascular complications affecting the large and small blood vessels.
We hypothesise that the presence of diabetes related vascular disease such as retinopathy may result in greater vulnerability and susceptibility to respiratory failure in severe COVID-19. Therefore, looking for presence or history of retinopathy or other vascular complications of diabetes may help health care professionals identify patients at high risk of severe COVID-19. Further studies are required to investigate the possible mechanisms that explain the links between markers and manifestations of diabetic vascular disease such as retinopathy and severe COVID-19.
Royal National Institute of Blind People (RBIB) specialist lead for eye health, Dr Louise Gow said:
RNIB hope this research will result in greater awareness of those who are most at risk of serious complications from COVID-19. With vaccine planning underway, consideration must be given to prioritising people with diabetic retinopathy. It also highlights that it is vital that information about COVID-19 is available in formats that are accessible to people with sight loss so that they know how to protect themselves.
Limitations of this study include its relatively small sample size and that, as it is a cross-sectional study, it is unable to identify a causal relationship between retinopathy and severe COVID-19 outcomes.
King’s Health Partners Diabetes, Endocrinology and Obesity is improving health and wellbeing for people living with diabetes and obesity across London and south east England.
Liked this article? Read five ways King’s Health Partners is improving outcomes for people with diabetes.